Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 407 participants.
Also called NCT03044574
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 407 participants
- Sponsor
- Registry
-
NCT03044574
-
- Other papers using this trial's data
- Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the RIDILOTT DVT study
- Intermittent Pneumatic Compression in Addition to Standard Prophylaxis of Postoperative Venous Thromboembolism in Extremely High-risk Patients (IPC SUPER): A Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Russia
- Registry status
- Completed
Technical summary
Registry record NCT03044574. Randomized; single masking; primary purpose prevention. Start 2017-02-01 (actual); primary completion 2018-09-30 (actual). Results posted on 2020-02-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism
- Acronym
- IPCSUPER
- Condition
- Venous Thromboembolism
- Condition
- Venous Thrombosis
- Intervention (Device)
- SCD
- Intervention (Device)
- GCS
- Intervention (Drug)
- LMWH
- Lead sponsor
- Pirogov Russian National Research Medical University
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct03044574- Content hash
7e6fae7e2873049dc18defb5bff30a8ac36bca441798c62a7f24a0768b2368bb